These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 23440732)

  • 61. A novel protein isoform of catechol O-methyltransferase (COMT): brain expression analysis in schizophrenia and bipolar disorder and effect of Val158Met genotype.
    Tunbridge EM; Weinberger DR; Harrison PJ
    Mol Psychiatry; 2006 Feb; 11(2):116-7. PubMed ID: 16247488
    [No Abstract]   [Full Text] [Related]  

  • 62. Genetic or pharmacological superoxide-hydrogen peroxide imbalances modulate the in vitro effects of lithium on glycogen synthase kinase-3β.
    Barbisan F; Azzolin VF; Monteiro GC; Teixeira CF; Mastella MH; Bueno V; Duarte MMMF; Wagner G; do Prado-Lima PAS; Ribeiro EE; da Cruz IBM
    Gene; 2018 May; 655():48-55. PubMed ID: 29466765
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Structure-based design leads to the identification of lithium mimetics that block mania-like effects in rodents. possible new GSK-3beta therapies for bipolar disorders.
    Kozikowski AP; Gaisina IN; Yuan H; Petukhov PA; Blond SY; Fedolak A; Caldarone B; McGonigle P
    J Am Chem Soc; 2007 Jul; 129(26):8328-32. PubMed ID: 17552518
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Association between glycogen synthase kinase-3beta genetic polymorphism and late-onset Alzheimer's disease.
    Mateo I; Infante J; Llorca J; Rodríguez E; Berciano J; Combarros O
    Dement Geriatr Cogn Disord; 2006; 21(4):228-32. PubMed ID: 16428884
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Identification of a glycogen synthase kinase-3β inhibitor that attenuates hyperactivity in CLOCK mutant mice.
    Kozikowski AP; Gunosewoyo H; Guo S; Gaisina IN; Walter RL; Ketcherside A; McClung CA; Mesecar AD; Caldarone B
    ChemMedChem; 2011 Sep; 6(9):1593-602. PubMed ID: 21732538
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Looking beyond the role of glycogen synthase kinase-3 genetic expression on electroretinogram response: what about lithium?
    Lavoie J; Hébert M; Beaulieu JM
    Biol Psychiatry; 2015 Feb; 77(3):e15-e17. PubMed ID: 25193244
    [No Abstract]   [Full Text] [Related]  

  • 67. Differential effects of DAAO on regional activation and functional connectivity in schizophrenia, bipolar disorder and controls.
    Papagni SA; Mechelli A; Prata DP; Kambeitz J; Fu CH; Picchioni M; Walshe M; Toulopoulou T; Bramon E; Murray RM; Collier DA; Bellomo A; McGuire P
    Neuroimage; 2011 Jun; 56(4):2283-91. PubMed ID: 21421061
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The association of DUSP6 gene with schizophrenia and bipolar disorder: its possible role in the development of bipolar disorder.
    Lee KY; Ahn YM; Joo EJ; Chang JS; Kim YS
    Mol Psychiatry; 2006 May; 11(5):425-6. PubMed ID: 16491131
    [No Abstract]   [Full Text] [Related]  

  • 69. Genetic deletion of glycogen synthase kinase-3beta abrogates activation of IkappaBalpha kinase, JNK, Akt, and p44/p42 MAPK but potentiates apoptosis induced by tumor necrosis factor.
    Takada Y; Fang X; Jamaluddin MS; Boyd DD; Aggarwal BB
    J Biol Chem; 2004 Sep; 279(38):39541-54. PubMed ID: 15252041
    [TBL] [Abstract][Full Text] [Related]  

  • 70. β-catenin promoter ChIP-chip reveals potential schizophrenia and bipolar disorder gene network.
    Pedrosa E; Shah A; Tenore C; Capogna M; Villa C; Guo X; Zheng D; Lachman HM
    J Neurogenet; 2010 Dec; 24(4):182-93. PubMed ID: 20615089
    [TBL] [Abstract][Full Text] [Related]  

  • 71. GSK-3 is a viable potential target for therapeutic intervention in bipolar disorder.
    Rowe MK; Wiest C; Chuang DM
    Neurosci Biobehav Rev; 2007; 31(6):920-31. PubMed ID: 17499358
    [TBL] [Abstract][Full Text] [Related]  

  • 72. An investigation of the Wnt-signalling pathway in the prefrontal cortex in schizophrenia, bipolar disorder and major depressive disorder.
    Beasley C; Cotter D; Everall I
    Schizophr Res; 2002 Nov; 58(1):63-7. PubMed ID: 12363391
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Potential Role of Glycogen Synthase Kinase-3β in Regulation of Myocardin Activity in Human Vascular Smooth Muscle Cells.
    Zhou YX; Shi Z; Singh P; Yin H; Yu YN; Li L; Walsh MP; Gui Y; Zheng XL
    J Cell Physiol; 2016 Feb; 231(2):393-402. PubMed ID: 26129946
    [TBL] [Abstract][Full Text] [Related]  

  • 74. A genome-wide meta-analysis identifies novel loci associated with schizophrenia and bipolar disorder.
    Wang KS; Liu XF; Aragam N
    Schizophr Res; 2010 Dec; 124(1-3):192-9. PubMed ID: 20889312
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Glycogen synthase kinase-3beta, mood stabilizers, and neuroprotection.
    Li X; Bijur GN; Jope RS
    Bipolar Disord; 2002 Apr; 4(2):137-44. PubMed ID: 12071511
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Possible involvement of post-dopamine D2 receptor signalling components in the pathophysiology of schizophrenia.
    Amar S; Shaltiel G; Mann L; Shamir A; Dean B; Scarr E; Bersudsky Y; Belmaker RH; Agam G
    Int J Neuropsychopharmacol; 2008 Mar; 11(2):197-205. PubMed ID: 17681085
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [The relationship between the Wnt signaling and the psychiatric diseases].
    Ferrero A; Cereseto M; Sifonios L
    Vertex; 2006; 17(67):165-71. PubMed ID: 16847474
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Interleukin-1 cluster is associated with genetic risk for schizophrenia and bipolar disorder.
    Papiol S; Rosa A; Gutiérrez B; Martín B; Salgado P; Catalán R; Arias B; Fañanás L
    J Med Genet; 2004 Mar; 41(3):219-23. PubMed ID: 14985387
    [No Abstract]   [Full Text] [Related]  

  • 79. The gender-specific association of rs334558 in GSK3β with major depressive disorder.
    Liu S; Wang L; Sun N; Yang C; Liu Z; Li X; Cao X; Xu Y; Zhang K
    Medicine (Baltimore); 2017 Jan; 96(3):e5928. PubMed ID: 28099358
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Mutant K-Ras increases GSK-3β gene expression via an ETS-p300 transcriptional complex in pancreatic cancer.
    Zhang JS; Koenig A; Harrison A; Ugolkov AV; Fernandez-Zapico ME; Couch FJ; Billadeau DD
    Oncogene; 2011 Aug; 30(34):3705-15. PubMed ID: 21441955
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.